rxstat › Classes › Direct Acting Antivirals
Direct Acting Antivirals: shortage status in Canada
15 of the 34 direct acting antivirals rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Adefovir Dipivoxil (Hepsera) Partial shortage 1 of 2 reported products affected
Atazanavir (Reyataz) Partial shortage 3 of 8 reported products affected
Darunavir (Prezista) Partial shortage 2 of 9 reported products affected · est. return Jul 31, 2026
Efavirenz (Sustiva) Partial shortage 1 of 6 reported products affected
Efavirenz Tenofovir Disoproxil Emtricitabine (Atripla) Partial shortage 3 of 7 reported products affected · est. return Dec 31, 2026
Entecavir (Baraclude) Partial shortage 2 of 5 reported products affected · est. return Aug 7, 2026
Famciclovir (Famvir) Partial shortage 3 of 17 reported products affected
Lamivudine (Heptovir) Partial shortage 1 of 6 reported products affected
Lamivudine Abacavir (Kivexa) Partial shortage 1 of 7 reported products affected
Nevirapine (Viramune) Partial shortage 1 of 6 reported products affected
Oseltamivir (Tamiflu) Partial shortage 1 of 6 reported products affected
Tenofovir Disoproxil Partial shortage 2 of 6 reported products affected
Tenofovir Disoproxil Emtricitabine Partial shortage 2 of 5 reported products affected
Valacyclovir (Valtrex) Partial shortage 4 of 21 reported products affected · est. return Nov 24, 2026
Valganciclovir (Valcyte) Partial shortage 2 of 6 reported products affected · est. return Feb 28, 2027
Abacavir (Ziagen) Shortage anticipated 0 of 3 reported products affected
Zidovudine Lamivudine (Combivir) Shortage anticipated 0 of 5 reported products affected
Asunaprevir (Sunvepra) Discontinued 0 of 1 reported products affected
Atazanavir Cobicistat (Evotaz) Discontinued 0 of 1 reported products affected
Delavirdine (Rescriptor) Discontinued 0 of 1 reported products affected
Didanosine (Videx) Discontinued 0 of 4 reported products affected
Emtricitabine (Emtriva) Discontinued 0 of 1 reported products affected
Enfuvirtide (Fuzeon) Discontinued 0 of 1 reported products affected
Fosamprenavir (Telzir) Discontinued 0 of 2 reported products affected
Inosine Pranobex (Imunovir) No current shortage
Letermovir (Prevymis) No current shortage
Nelfinavir (Viracept -250mg) Discontinued 0 of 2 reported products affected
Ombitasvir Paritaprevir Ritonavir (Technivie) Discontinued 0 of 1 reported products affected
Ritonavir Ombitasvir Dasabuvir Paritaprevir (Holkira Pak) Discontinued 0 of 1 reported products affected
Saquinavir (Invirase -) Discontinued 0 of 2 reported products affected
Stavudine (Zerit -) Discontinued 0 of 4 reported products affected
Telbivudine (Sebivo) Discontinued 0 of 1 reported products affected
Tipranavir (Aptivus) Discontinued 0 of 1 reported products affected
Zidovudine Abacavir Lamivudine (Trizivir) Discontinued 0 of 2 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.